Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion

被引：9
|
作者：
Cudillo, L. [1 ]
Cerretti, R. [1 ]
Baliva, G. [2 ]
De Angelis, G. [1 ]
Postorino, M. [1 ]
Picardi, A. [1 ]
Mirabile, M. [1 ]
Lanti, A. [3 ]
Cantonetti, M. [1 ]
Arcese, W. [1 ]
机构：
[1] Univ Roma Tor Vergata, Stem Cell Transplant Unit, Rome, Italy
[2] IRCCS, Dermatopat Immacolata Inst, Rome, Italy
[3] Univ Roma Tor Vergata, Blood Bank, Rome, Italy
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷 / 04期
关键词：
STEM-CELL TRANSPLANTATION; ADVANCED MYCOSIS-FUNGOIDES;
D O I：
10.1038/bmt.2008.333
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：347 / 348
页数：2
相关论文
共 50 条
  • [1] Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion
    L Cudillo
    R Cerretti
    G Baliva
    G De Angelis
    M Postorino
    A Picardi
    M Mirabile
    A Lanti
    M Cantonetti
    W Arcese
    Bone Marrow Transplantation, 2009, 43 : 347 - 348
  • [2] Extramedullary relapse in patients treated by donor lymphocyte infusion for haematological relapse after allogeneic bone marrow transplant
    Bordon, V
    De Moerloose, B
    Vandecruys, E
    Dhooge, C
    Benoit, Y
    Laureys, G
    BONE MARROW TRANSPLANTATION, 2005, 35 : S344 - S344
  • [3] Outcomes after Second Allogeneic Transplantation and Donor Lymphocyte Infusion for Relapse after a First Allogeneic Transplant
    Lemieux, Christopher
    Muffly, Lori S.
    Arai, Sally
    Rezvani, Andrew R.
    Sidana, Surbhi
    Johnston, Laura J.
    Weng, Wen-Kai
    Shiraz, Parveen
    Frank, Matthew J.
    Meyer, Everett H.
    Shizuru, Judith A.
    Miklos, David B.
    Negrin, Robert S.
    Lowsky, Robert
    BLOOD, 2020, 136
  • [4] Donor lymphocyte infusion management and impact on transplant outcome after reduced intensity conditioning allogeneic transplantation.
    Michallet, M
    Le, QH
    Michallet, AS
    Thiebaut, A
    Tavernier, E
    Rafii, H
    Revesz, D
    Troncy, J
    Praire, A
    Gadolet, E
    Dubois, V
    Gebuhrer, L
    Hequet, O
    Bourgeot, JP
    Nicolini, FE
    BLOOD, 2004, 104 (11) : 634A - 634A
  • [5] Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome
    S Depil
    E Deconinck
    N Milpied
    L Sutton
    F Witz
    J P Jouet
    G Damaj
    I Yakoub-Agha
    Bone Marrow Transplantation, 2004, 33 : 531 - 534
  • [6] Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome
    Depil, S
    Deconinck, E
    Milpied, N
    Sutton, L
    Witz, F
    Jouet, JP
    Damaj, G
    Yakoub-Agha, I
    BONE MARROW TRANSPLANTATION, 2004, 33 (05) : 531 - 534
  • [7] Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome
    Yakoub-Agha, I
    Depil, S
    Deconninck, E
    Milpied, N
    Sutton, L
    Witz, F
    Jouet, JP
    BONE MARROW TRANSPLANTATION, 2003, 31 : S182 - S182
  • [8] Role of TSEBI at relapse after allogeneic transplant in mycosis fungoides and sezary syndrome
    Simontacchi, Gabriele
    Mattioli, Chiara
    Onida, Francesco
    Marrazzo, Livia
    Cela, Doruntina
    Vagge, Stefano
    Schiavone, Concetta
    Grandi, Vieri
    Pimpinelli, Nicola
    Mangoni, Monica
    Olmetto, Emanuela
    Chila, Debora
    Livi, Lorenzo
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1170 - S1172
  • [9] Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion
    Shah, Neal
    Rakszawski, Kevin
    Nickolich, Myles
    Ehmann, Christopher
    Wirk, Baldeep
    Naik, Seema
    Rybka, Witold
    Zheng, Hong
    Mierski, Joseph
    Silar, Brooke
    Mackey, Gina
    Greiner, Robert
    Brown, Valerie
    Claxton, David
    Mineishi, Shin
    Minagawa, Kentaro
    ANNALS OF HEMATOLOGY, 2021, 100 (10) : 2585 - 2592
  • [10] Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion
    Neal Shah
    Kevin Rakszawski
    Myles Nickolich
    Christopher Ehmann
    Baldeep Wirk
    Seema Naik
    Witold Rybka
    Hong Zheng
    Joseph Mierski
    Brooke Silar
    Gina Mackey
    Robert Greiner
    Valerie Brown
    David Claxton
    Shin Mineishi
    Kentaro Minagawa
    Annals of Hematology, 2021, 100 : 2585 - 2592
12345